BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10818168)

  • 1. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists.
    Swerdlow NR; Martinez ZA; Hanlon FM; Platten A; Farid M; Auerbach P; Braff DL; Geyer MA
    J Neurosci; 2000 Jun; 20(11):4325-36. PubMed ID: 10818168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains.
    Swerdlow NR; Shoemaker JM; Platten A; Pitcher L; Goins J; Crain S
    Pharmacol Biochem Behav; 2003 Apr; 75(1):191-7. PubMed ID: 12759127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heritable differences in the dopaminergic regulation of sensorimotor gating. I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny.
    Swerdlow NR; Shoemaker JM; Platten A; Pitcher L; Goins J; Auerbach PP
    Psychopharmacology (Berl); 2004 Aug; 174(4):441-51. PubMed ID: 15300358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity to sensorimotor gating-disruptive effects of apomorphine in two outbred parental rat strains and their F1 and N2 progeny.
    Swerdlow NR; Platten A; Hanlon FM; Martinez ZA; Printz MP; Auerbach P
    Neuropsychopharmacology; 2003 Feb; 28(2):226-34. PubMed ID: 12589375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants.
    Swerdlow NR; Platten A; Kim YK; Gaudet I; Shoemaker J; Pitcher L; Auerbach P
    Pharmacol Biochem Behav; 2001; 70(2-3):219-26. PubMed ID: 11701191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition.
    Swerdlow NR; Shoemaker JM; Auerbach PP; Pitcher L; Goins J; Platten A
    Psychopharmacology (Berl); 2004 Aug; 174(4):452-62. PubMed ID: 15300359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity.
    Kinney GG; Wilkinson LO; Saywell KL; Tricklebank MD
    J Neurosci; 1999 Jul; 19(13):5644-53. PubMed ID: 10377370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat strain differences in startle gating-disruptive effects of apomorphine occur with both acoustic and visual prepulses.
    Weber M; Swerdlow NR
    Pharmacol Biochem Behav; 2008 Jan; 88(3):306-11. PubMed ID: 17900675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats.
    Breier MR; Lewis B; Shoemaker JM; Light GA; Swerdlow NR
    Behav Brain Res; 2010 Apr; 208(2):560-5. PubMed ID: 20080128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating.
    Swerdlow NR; Breier M; Mora AB; Ko D; Shoemaker JM
    Pharmacol Biochem Behav; 2008 Jan; 88(3):280-90. PubMed ID: 17936348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural basis for a heritable phenotype: differences in the effects of apomorphine on startle gating and ventral pallidal GABA efflux in male Sprague-Dawley and Long-Evans rats.
    Qu Y; Saint Marie RL; Breier MR; Ko D; Stouffer D; Parsons LH; Swerdlow NR
    Psychopharmacology (Berl); 2009 Dec; 207(2):271-80. PubMed ID: 19756524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathways.
    Shilling PD; Saint Marie RL; Shoemaker JM; Swerdlow NR
    Biol Psychiatry; 2008 Apr; 63(8):748-58. PubMed ID: 18083141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heritable differences in the dopaminergic regulation of behavior in rats: relationship to D2-like receptor G-protein function.
    Swerdlow NR; Krupin AS; Bongiovanni MJ; Shoemaker JM; Goins JC; Hammer RP
    Neuropsychopharmacology; 2006 Apr; 31(4):721-9. PubMed ID: 16123742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic differences in startle gating-disruptive effects of apomorphine: evidence for central mediation.
    Swerdlow NR; Shoemaker JM; Pitcher L; Platten A; Kuczenski R; Eleey CC; Auerbach P
    Behav Neurosci; 2002 Aug; 116(4):682-90. PubMed ID: 12148935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.
    Weber M; Chang WL; Breier M; Ko D; Swerdlow NR
    Behav Pharmacol; 2008 Dec; 19(8):786-95. PubMed ID: 19020413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.
    Frau R; Mosher LJ; Bini V; Pillolla G; Pes R; Saba P; Fanni S; Devoto P; Bortolato M
    Psychoneuroendocrinology; 2016 Jan; 63():59-67. PubMed ID: 26415119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of sensitization to the effects of d-amphetamine and apomorphine on sensorimotor gating in rats.
    Druhan JP; Geyer MA; Valentino RJ
    Psychopharmacology (Berl); 1998 Feb; 135(3):296-304. PubMed ID: 9498734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia.
    Elmer GI; Sydnor J; Guard H; Hercher E; Vogel MW
    Psychopharmacology (Berl); 2004 Jul; 174(2):177-89. PubMed ID: 14985933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats.
    Swerdlow NR; Shilling PD; Breier M; Trim RS; Light GA; Marie RS
    Psychopharmacology (Berl); 2012 Dec; 224(3):349-62. PubMed ID: 22700037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.